Metin Uzman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Metin Uzman has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Evrim Kahramanoğlu Aksoy
Department of Gastroenterology, Ankara Atatürk Sanatoryum Training and Research Hospital, University of Health Sciences, 06290 Ankara, Türkiye
10 shared publications - Ferdane Sapmaz
Sağlık Bilimleri Üniversitesi, Keçiören Eğitim ve Araştırma Hastanesi, Gastroenteroloji Bölümü, Ankara
8 shared publications - Muhammet Yener Akpinar
Sağlık Bilimleri Üniversitesi Gülhane Eğitim ve Araştırma Hastanesi
7 shared publications - Gülçin Güler Şi̇mşek
Department of Pathology University of Health Sciences Gülhane Training and Research Hospital Ankara Turkey
4 shared publications - Yaşar Nazlıgül
Sağlık Bilimleri Üniversitesi, Keçiören Eğitim ve Araştırma Hastanesi, Gastroenteroloji Bölümü, Ankara
4 shared publications - Doğan Öztürk
Ankara Atatürk Sanatoryum EAH
2 shared publications
Latest Publications
- 16 October 2026
- Published by Elsevier in Cancer Epidemiology
- Vol. 105, 103255
Hepatocellular carcinoma in Turkey: A nationwide health system database analysis of clinical patterns and survival
- 16 October 2026
- Published by Elsevier in Cancer Epidemiology
- Vol. 105, 103255
Hepatocellular carcinoma in Turkey: A nationwide health system database analysis of clinical patterns and survival
- Open Access
- 12 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (24) , e49328
Assessment of fibrosis in chronic hepatitis B using APRI, FIB-4, FIB-5, FIB-6, and S-Index: Comparison with histology
Chronic hepatitis B (CHB) remains a major cause of cirrhosis and hepatocellular carcinoma worldwide. Although liver biopsy is the reference standard for fibrosis staging, its limitations have prompted the development of noninvasive serum-based indices. This study aimed to compare aminotransferase-to-platelet ratio index (APRI), Fibrosis-4 index (FIB-4), Fibrosis-5 index (FIB-5), Fibrosis-6 index (FIB-6), and serum fibrozis indeksi (S-Index) with histology in patients with CHB. A total of 191 CHB patients who underwent liver biopsy between 2012 and 2024 were retrospectively analyzed. Fibrosis was staged using the METAVIR system and classified as non-significant (F0–F2) or significant (F3–F4). Serum-based fibrosis indices were calculated, and their diagnostic performance was assessed using receiver operating characteristic (ROC) analysis. Of the 191 patients, 75 (39.3%) had significant fibrosis (SF). APRI, FIB-4, FIB-6, and S-Index were significantly higher in patients with SF, whereas FIB-5 showed no discriminatory value. ROC analysis demonstrated modest accuracy overall: APRI (area under the curve [AUC] 0.661) provided the highest sensitivity but low specificity (88.0% and 38.8% respectively, P < .001), while FIB-4 (AUC 0.601, specificity 86.2% sensitivity 37.3%, P = .019) and FIB-6 (AUC 0.608, specificity 87.1%, sensitivity 44%, P = .014) were more specific but less sensitive. S-Index showed intermediate performance (AUC 0.601, specificity 62.07% sensitivity 58.67%, P = .021). Serum-based indices demonstrated limited but clinically relevant ability to discriminate SF in CHB, with modest AUC values. Despite their suboptimal diagnostic accuracy, their noninvasive, low-cost, and accessible nature supports their potential role in clinical practice. APRI showed high sensitivity but low specificity, limiting its standalone screening utility. FIB-4 and FIB-6 displayed relatively balanced performance, while S-Index showed modest but consistent accuracy. Overall, these scores may serve as adjunctive tools rather than definitive diagnostic methods and could have a role in longitudinal monitoring. Further validation in larger, multicenter prospective studies is warranted.
- 12 June 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (24) , e49328
Open AccessAssessment of fibrosis in chronic hepatitis B using APRI, FIB-4, FIB-5, FIB-6, and S-Index: Comparison with histology
Chronic hepatitis B (CHB) remains a major cause of cirrhosis and hepatocellular carcinoma worldwide. Although liver biopsy is the reference standard for fibrosis staging, its limitations have prompted the development of noninvasive serum-based indices. This study aimed to compare aminotransferase-to-platelet ratio index (APRI), Fibrosis-4 index (FIB-4), Fibrosis-5 index (FIB-5), Fibrosis-6 index (FIB-6), and serum fibrozis indeksi (S-Index) with histology in patients with CHB. A total of 191 CHB patients who underwent liver biopsy between 2012 and 2024 were retrospectively analyzed. Fibrosis was staged using the METAVIR system and classified as non-significant (F0–F2) or significant (F3–F4). Serum-based fibrosis indices were calculated, and their diagnostic performance was assessed using receiver operating characteristic (ROC) analysis. Of the 191 patients, 75 (39.3%) had significant fibrosis (SF). APRI, FIB-4, FIB-6, and S-Index were significantly higher in patients with SF, whereas FIB-5 showed no discriminatory value. ROC analysis demonstrated modest accuracy overall: APRI (area under the curve [AUC] 0.661) provided the highest sensitivity but low specificity (88.0% and 38.8% respectively, P < .001), while FIB-4 (AUC 0.601, specificity 86.2% sensitivity 37.3%, P = .019) and FIB-6 (AUC 0.608, specificity 87.1%, sensitivity 44%, P = .014) were more specific but less sensitive. S-Index showed intermediate performance (AUC 0.601, specificity 62.07% sensitivity 58.67%, P = .021). Serum-based indices demonstrated limited but clinically relevant ability to discriminate SF in CHB, with modest AUC values. Despite their suboptimal diagnostic accuracy, their noninvasive, low-cost, and accessible nature supports their potential role in clinical practice. APRI showed high sensitivity but low specificity, limiting its standalone screening utility. FIB-4 and FIB-6 displayed relatively balanced performance, while S-Index showed modest but consistent accuracy. Overall, these scores may serve as adjunctive tools rather than definitive diagnostic methods and could have a role in longitudinal monitoring. Further validation in larger, multicenter prospective studies is warranted.
- 31 October 2023
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 76 (4) , 328-332
Zonulin is not Useful for the Diagnosis of Intestinal Permeability in Cirrhotic
- 31 October 2023
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 76 (4) , 328-332
Zonulin is not Useful for the Diagnosis of Intestinal Permeability in Cirrhotic
- 22 March 2021
- Published by Walter de Gruyter GmbH in Journal of Basic and Clinical Physiology and Pharmacology
- Vol. 33 (4) , 471-475
Effects of sleeve gastrectomy on neutrophil–lymphocyte ratio
Objectives: Obesity and related diseases have become one of the most important health problems in the modern age. In addition to its clinical use in the treatment of obesity, bariatric surgery reduces obesity-induced inflammation. Neutrophil–lymphocyte ratio (NLR) is a cheap and easily attainable inflammatory marker. The purpose of this study is to show the effect of bariatric surgery on NLR at preoperative and postoperative 3rd, 6th, and 12th months after SG. Methods: 298 patients, who underwent sleeve gastrectomy (SG) in general surgery clinic between 2015 and 2017, were included in the study. We excluded the patients younger than 18 years old, and did not have any inflammatory, infectious, hematological, and comorbide diseases such as diabetes mellitus, cardiovascular diseases, ischemic heart disease, hypertension, renal insufficiency, cancer, and respiratory problems like asthma, obstructive sleep apnea syndrome. We evaluated the levels of NLR at preoperative and postoperative 3rd, 6th, and 12th months visits. Results: There were a total of 298 adult patients (age: mean 38.6, minimum 18, maximum 69 years old). Of whom 247 were female (82.9%) and 51 were male (17.1%). We found that NLR levels decreased significantly at 3rd, 6th, and 12th month visits after SG (p<0.001). Conclusions: We concluded that NLR levels decrease after surgery in a proportional reduction in adipose tissue. The decrease in NLR levels may also be associated with the protective effects of sleeve gastrectomy against low-grade inflammation-related diseases.
- 22 March 2021
- Published by Walter de Gruyter GmbH in Journal of Basic and Clinical Physiology and Pharmacology
- Vol. 33 (4) , 471-475
Effects of sleeve gastrectomy on neutrophil–lymphocyte ratio
Objectives: Obesity and related diseases have become one of the most important health problems in the modern age. In addition to its clinical use in the treatment of obesity, bariatric surgery reduces obesity-induced inflammation. Neutrophil–lymphocyte ratio (NLR) is a cheap and easily attainable inflammatory marker. The purpose of this study is to show the effect of bariatric surgery on NLR at preoperative and postoperative 3rd, 6th, and 12th months after SG. Methods: 298 patients, who underwent sleeve gastrectomy (SG) in general surgery clinic between 2015 and 2017, were included in the study. We excluded the patients younger than 18 years old, and did not have any inflammatory, infectious, hematological, and comorbide diseases such as diabetes mellitus, cardiovascular diseases, ischemic heart disease, hypertension, renal insufficiency, cancer, and respiratory problems like asthma, obstructive sleep apnea syndrome. We evaluated the levels of NLR at preoperative and postoperative 3rd, 6th, and 12th months visits. Results: There were a total of 298 adult patients (age: mean 38.6, minimum 18, maximum 69 years old). Of whom 247 were female (82.9%) and 51 were male (17.1%). We found that NLR levels decreased significantly at 3rd, 6th, and 12th month visits after SG (p<0.001). Conclusions: We concluded that NLR levels decrease after surgery in a proportional reduction in adipose tissue. The decrease in NLR levels may also be associated with the protective effects of sleeve gastrectomy against low-grade inflammation-related diseases.
- 28 October 2020
- Published by Galenos Yayinevi in Eurasian Journal of Emergency Medicine
- Vol. 19 (4) , 197-202
Predictors of Mortality in Geriatric Patients with Upper Gastrointestinal Bleeding
- 28 October 2020
- Published by Galenos Yayinevi in Eurasian Journal of Emergency Medicine
- Vol. 19 (4) , 197-202
Predictors of Mortality in Geriatric Patients with Upper Gastrointestinal Bleeding
- 30 April 2020
- Published by Endoscopy Gastrointestinal in Endoskopi Gastrointestinal
- Vol. 28 (1) , 28-30
Masif Alt Gastrointestinal Sistem Kanamasının Nadir Bir Nedeni: İntestinal Tüberkülozis
En tr Intestinal tuberculosis is the infection of the gastrointestinal tract by tuberculosis bacilli. The most commonly affected area is the ileocecal region. A careful differential diagnosis between Crohn’s disease and intestinal tuberculosis is required because similar areas are involved in both these diseases. Intestinal tuberculosis often presents non-specific complaints in the clinic. Chronic bleeding is often observed in these patients. However, massive bleeding has been reported very rarely in the literature. Herein, we present a patient with intestinal tuberculosis for whom hemostasis was achieved by surgical bowel resection. İntestinal tüberkülozis, gastrointestinal sistemin tüberküloz basili ile enfekte olma halidir. En sık tutulan bölge ileoçekal alandır. Tutulum yerlerinin benzer olması Crohn hastalığı ile dikkatli bir şekilde ayırıcı tanısının yapılmasını gerektirir. İntestinal tüberküloz klinikte sıklıkla non-spesifik şikayetlerle kendini belli eder. Kanama bu hastalarda sıklıkla kronik seyirlidir. Masif kanama literatürde çok nadir olarak bildirilmiştir. Biz burada cerrahi barsak rezeksiyonu ile hemostazın sağlanabildiği intestinal tüberkülozlu hastamızı sunduk. ,
- 30 April 2020
- Published by Endoscopy Gastrointestinal in Endoskopi Gastrointestinal
- Vol. 28 (1) , 28-30
Masif Alt Gastrointestinal Sistem Kanamasının Nadir Bir Nedeni: İntestinal Tüberkülozis
En tr Intestinal tuberculosis is the infection of the gastrointestinal tract by tuberculosis bacilli. The most commonly affected area is the ileocecal region. A careful differential diagnosis between Crohn’s disease and intestinal tuberculosis is required because similar areas are involved in both these diseases. Intestinal tuberculosis often presents non-specific complaints in the clinic. Chronic bleeding is often observed in these patients. However, massive bleeding has been reported very rarely in the literature. Herein, we present a patient with intestinal tuberculosis for whom hemostasis was achieved by surgical bowel resection. İntestinal tüberkülozis, gastrointestinal sistemin tüberküloz basili ile enfekte olma halidir. En sık tutulan bölge ileoçekal alandır. Tutulum yerlerinin benzer olması Crohn hastalığı ile dikkatli bir şekilde ayırıcı tanısının yapılmasını gerektirir. İntestinal tüberküloz klinikte sıklıkla non-spesifik şikayetlerle kendini belli eder. Kanama bu hastalarda sıklıkla kronik seyirlidir. Masif kanama literatürde çok nadir olarak bildirilmiştir. Biz burada cerrahi barsak rezeksiyonu ile hemostazın sağlanabildiği intestinal tüberkülozlu hastamızı sunduk. ,
- 18 September 2019
- Published by Endoscopy Gastrointestinal in Endoskopi Gastrointestinal
- Vol. 27 (2) , 52-55
Linitis plastikadan ne zaman şüphe edilmeli? Ne kadar şüphe edilmeli?
En tr Background and Aims: Linitis plastica is known as diffuse infiltrative gastric carcinoma and has the worst prognosis. Because it does not have a specific endoscopic appearance, diagnosing this condition is difficult. Even if it is suspected in endoscopy, its pathology is also challenging to comprehend. Here we presented our patients with linitis plastica and their endoscopic appearances. Materials and Methods: This is a retrospective study conducted in Kecioren Training and Research Hospital between 2009 and 2019. Individuals with an initial endoscopic diagnosis of linitis plastica were enrolled. Results: Overall, 28 patients were suspected for linitis plastica; but only 5 had pathologic diagnosis. These 5 patients had similar endoscopic characteristics, such as gastric expansion limitation, hypertrophic gastric folds, erosions, and mucosal ulcers. Conclusion: There is no specific endoscopic appearance of linitis plastica; however, clinical suspicion must be high in individuals who have gastric expansion limitation and hypertrophic gastric folds. It must not be surprising if the first endoscopic biopsy result is negative for adenocarcinoma in these patients. Giriş ve Amaç: Linitis plastika, diffüz infiltratif mide kanseri olup kötü prognoza sahiptir. Endoskopik olarak spesifik bir bulgusu olmadığı için tanınması güçtür. Endoskopik olarak şüphe edilse bile biyopsi ile tanı koymak da zor olabilir. Biz burada kliniğimizde linitis plastika tanısı konulan olgularımızı endoskopik özellikleri ile beraber paylaştık. Gereç ve Yöntem: Bu çalışma retrospektif olarak Keçiören Eğitim ve Araştırma Hastanesi, Gastroenteroloji Kliniğinde 2009-2019 tarihleri arasında yürütülmüştür. Endoskopilerinde linitis plastika ön tanısı olan olgular bu tarihler arasında toplanmıştır. Bulgular: Toplam 28 hastadan linitis plastika ön tanısı ile biyopsi alınmış, bu olguların 5 tanesinde linitis plastika tanısı konulmuştur. Linitis plastika olan olguların hepsinde endoskopik olarak mide ekspansiyonunda kısıtlılık, gastrik foldlarda belirginleşme, mukozal erozyon ve ülserler vardı. Sonuç: Linitis plastik için belirtilmiş tipik bir endoskopik bulgu olmayıp mide ekspansiyonunda kısıtlılık ve gastrik foldlarda belirginleşme olan olgularda klinik şüphenin yüksek olması gerekir. İlk biyopsilerde linitis plastika tanısının konulmaması da sürpriz olmamalıdır.
- 18 September 2019
- Published by Endoscopy Gastrointestinal in Endoskopi Gastrointestinal
- Vol. 27 (2) , 52-55
Linitis plastikadan ne zaman şüphe edilmeli? Ne kadar şüphe edilmeli?
En tr Background and Aims: Linitis plastica is known as diffuse infiltrative gastric carcinoma and has the worst prognosis. Because it does not have a specific endoscopic appearance, diagnosing this condition is difficult. Even if it is suspected in endoscopy, its pathology is also challenging to comprehend. Here we presented our patients with linitis plastica and their endoscopic appearances. Materials and Methods: This is a retrospective study conducted in Kecioren Training and Research Hospital between 2009 and 2019. Individuals with an initial endoscopic diagnosis of linitis plastica were enrolled. Results: Overall, 28 patients were suspected for linitis plastica; but only 5 had pathologic diagnosis. These 5 patients had similar endoscopic characteristics, such as gastric expansion limitation, hypertrophic gastric folds, erosions, and mucosal ulcers. Conclusion: There is no specific endoscopic appearance of linitis plastica; however, clinical suspicion must be high in individuals who have gastric expansion limitation and hypertrophic gastric folds. It must not be surprising if the first endoscopic biopsy result is negative for adenocarcinoma in these patients. Giriş ve Amaç: Linitis plastika, diffüz infiltratif mide kanseri olup kötü prognoza sahiptir. Endoskopik olarak spesifik bir bulgusu olmadığı için tanınması güçtür. Endoskopik olarak şüphe edilse bile biyopsi ile tanı koymak da zor olabilir. Biz burada kliniğimizde linitis plastika tanısı konulan olgularımızı endoskopik özellikleri ile beraber paylaştık. Gereç ve Yöntem: Bu çalışma retrospektif olarak Keçiören Eğitim ve Araştırma Hastanesi, Gastroenteroloji Kliniğinde 2009-2019 tarihleri arasında yürütülmüştür. Endoskopilerinde linitis plastika ön tanısı olan olgular bu tarihler arasında toplanmıştır. Bulgular: Toplam 28 hastadan linitis plastika ön tanısı ile biyopsi alınmış, bu olguların 5 tanesinde linitis plastika tanısı konulmuştur. Linitis plastika olan olguların hepsinde endoskopik olarak mide ekspansiyonunda kısıtlılık, gastrik foldlarda belirginleşme, mukozal erozyon ve ülserler vardı. Sonuç: Linitis plastik için belirtilmiş tipik bir endoskopik bulgu olmayıp mide ekspansiyonunda kısıtlılık ve gastrik foldlarda belirginleşme olan olgularda klinik şüphenin yüksek olması gerekir. İlk biyopsilerde linitis plastika tanısının konulmaması da sürpriz olmamalıdır.
- 1 August 2019
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 72 (2) , 179-183
Long-term Follow-up Results of Patients with Percutaneous Endoscopic Gastrostomy and Factors Affecting Survival
- 1 August 2019
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 72 (2) , 179-183
Long-term Follow-up Results of Patients with Percutaneous Endoscopic Gastrostomy and Factors Affecting Survival
- Open Access
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Gastroenterology Review
- Vol. 14 (3) , 183-187
The importance of complete blood count parameters in the screening of gastric cancer
Introduction Gastric cancer is ranked fourth among all cancers in the world and second in cancer-related deaths. Gastritis leads to the activation of neutrophils, lymphocytes, macrophages, and platelets. Long-term inflammation leads to multistage histopathologic changes called Correa tract,...
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Gastroenterology Review
- Vol. 14 (3) , 183-187
Open AccessThe importance of complete blood count parameters in the screening of gastric cancer
Introduction Gastric cancer is ranked fourth among all cancers in the world and second in cancer-related deaths. Gastritis leads to the activation of neutrophils, lymphocytes, macrophages, and platelets. Long-term inflammation leads to multistage histopathologic changes called Correa tract,...
- Open Access
- 29 December 2018
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 17 (3) , 117-122
Precancerous lesions effects on the eradication of Helicobacter pylori
Giriş ve Amaç: Mide mukozasındaki Helicobacter pylori yoğunluğu, inflamasyonun aktivite derecesi, gastrit şiddeti ile eradikayon başarısı arasındaki ilişkiyi gösteren çalışma sayısı sınırlıdır. Biz çalışmamamızda; Helicobacter pylori eradikasyon başarısı üzerine gastrit şiddetinin ve Sidney klasifikasyon parametrelerinin etkisini araştırmayı amaçladık. Gereç ve Yöntem: Çalışmaya; Temmuz 2017 ve Aralık 2017 tarihleri arasında Keçiören Eğitim ve Araştırma Hastanesi’nde Helicobacter pylori enfeksiyonu patoloji olarak konmuş, eradikasyon için bizmut içeren standart dörtlü tedaviyi tamamlayan hastalar dahil edildi. Bulgular: Çalışmaya toplam 634 hasta dahil edildi. Antrumda atrofi varlığında Helicobacter pylori eradikasyon başarısı düşükken, intestinal metaplazi varlığında eradikasyon başarısı etkilenmemiştir (sırasıyla p=0,025 ve p >0,05); benzer şekilde korpustaki atrofi ve intestinal metaplazi olan grupta da eradikasyon başarısı daha azdı (sırasıyla p=0,016 ve p=0,01). Şiddetli gastrit gruplarında eradikasyon başarısızlığı daha fazlaydı (OLGA III-IV için p=0.015, OLGIM III-IV için p=0.032). Multiple lineer regresyon analizinde değerlendirildiğinde korpus intestinal metaplazi ve lenfoid agregasyon şiddeti bağımsız risk faktörü olarak değerlendirilmiştir (sırasıyla p=0.002 ve p=0.042). Sonuç: Gastrit ciddiyeti, intestinal metaplazi ve gastrik atrofi Helicobacter pylori eradikasyon tedavisi başarısı üzerinde negatif etki göstermektedir. Bu yüzden, patolojilerinde bu özelliklere sahip olan hastalarda tedavi protokolü ve tedavi süresi yeniden gözden geçirilmelidir.
- 29 December 2018
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 17 (3) , 117-122
Open AccessPrecancerous lesions effects on the eradication of Helicobacter pylori
Giriş ve Amaç: Mide mukozasındaki Helicobacter pylori yoğunluğu, inflamasyonun aktivite derecesi, gastrit şiddeti ile eradikayon başarısı arasındaki ilişkiyi gösteren çalışma sayısı sınırlıdır. Biz çalışmamamızda; Helicobacter pylori eradikasyon başarısı üzerine gastrit şiddetinin ve Sidney klasifikasyon parametrelerinin etkisini araştırmayı amaçladık. Gereç ve Yöntem: Çalışmaya; Temmuz 2017 ve Aralık 2017 tarihleri arasında Keçiören Eğitim ve Araştırma Hastanesi’nde Helicobacter pylori enfeksiyonu patoloji olarak konmuş, eradikasyon için bizmut içeren standart dörtlü tedaviyi tamamlayan hastalar dahil edildi. Bulgular: Çalışmaya toplam 634 hasta dahil edildi. Antrumda atrofi varlığında Helicobacter pylori eradikasyon başarısı düşükken, intestinal metaplazi varlığında eradikasyon başarısı etkilenmemiştir (sırasıyla p=0,025 ve p >0,05); benzer şekilde korpustaki atrofi ve intestinal metaplazi olan grupta da eradikasyon başarısı daha azdı (sırasıyla p=0,016 ve p=0,01). Şiddetli gastrit gruplarında eradikasyon başarısızlığı daha fazlaydı (OLGA III-IV için p=0.015, OLGIM III-IV için p=0.032). Multiple lineer regresyon analizinde değerlendirildiğinde korpus intestinal metaplazi ve lenfoid agregasyon şiddeti bağımsız risk faktörü olarak değerlendirilmiştir (sırasıyla p=0.002 ve p=0.042). Sonuç: Gastrit ciddiyeti, intestinal metaplazi ve gastrik atrofi Helicobacter pylori eradikasyon tedavisi başarısı üzerinde negatif etki göstermektedir. Bu yüzden, patolojilerinde bu özelliklere sahip olan hastalarda tedavi protokolü ve tedavi süresi yeniden gözden geçirilmelidir.